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  Introduction 
 Adolescence is a period characterised by extensive physical, 
emotional, social, and cognitive change. Depressive feelings 
and/or low self-esteem are common in adolescents and 
have been associated with long-term negative health and 
social outcomes. Multiple studies have shown an 
association between long-chain polyunsaturated fatty acids 
and depression in adults. Research on whether this is also 
the case in adolescents from the general population is 
scarce. We studied the effect of 1 year krill oil 
supplementation on depression and self-esteem in typically  
developing adolescents. Data from Food2Learn, a double-
blind, randomised, placebo controlled supplementation trial 
in typically developing adolescents, were used.  
   Results   
Figure 1: Omega-3 Index of participants in blood measured at 
baseline, 3, 6 and 12 months (mean ± sd) .  
Mixed models did not show a significant effect of krill oil 
supplementation on depression score  
(β = -1.37, p = 0.235, 95% CI [-3.59 to 0.84]), nor a significant 
relationship between Omega-3 Index and depression score  
(β = 0.30, p = 0.325, 95% CI [-0.30 to 0.90]). Furthermore,  
there was no significant effect of krill oil supplementation on  
self-esteem (β = 0.62, p = 0.375, 95% CI[-0.72 to 1.96]), nor  
an significant relationship between Omega-3 Index and  
self-esteem score (β = -0.09, p = 0.608, 95% CI [-0.42 to 0.24]).  
 
Methods  
Design: double-blind, randomised, placebo-controlled 
supplementation trial with repeated measurements. 
Population: healthy adolescents age 13-15 yr. attending 
lower secondary general education (n= 266) with an  
Omega-3 Index <5% were randomised to either placebo or 
krill oil supplementation (520mg EPA, 280mg DHA per day) 
for 1 year.  
Independent variable: intervention condition (krill oil or 
placebo) and Omega-3 Index measured in blood.  
Dependent variables: the Dutch version of the Centre for 
Epidemiologic Studies Depression Scale (CESD-D) and the 
Rosenberg Self-Esteem Scale (RSE).  
Data analyses: mixed models that accounted for correlations 
of follow-up measurements within participants and adjusted 
for the baseline measurements and covariates. 
Covariates: smoking, alcohol consumption, age, sex, BMI, 
parental education level and cohort number.  
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Conclusion 
The study did not show a significant effect of one year of krill 
oil supplementation on either depression or self-esteem 
score. Moreover, no significant relationship between  
Omega-3 Index and either depression or self-esteem score 
was shown in this sample of typically developing students of 
the lower general secondary education in the Netherlands. 
Unfortunately, the majority of the students randomised to 
the krill oil condition did not achieve the target Omega-3 
Index of  8-11%, possibly due to non-compliance. More 
research in this important age group is necessary.  
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Figure 2: Scores on the CES-D and RSE at baseline, 6 months and 12 
months separated for placebo and krill group (mean and 95%CI). 
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